| Literature DB >> 36204651 |
Tiana M Scott1, Antonio Solis-Leal1,2, J Brandon Lopez1, Richard A Robison1, Bradford K Berges1, Brett E Pickett1.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China in December 2019 and caused a global pandemic resulting in millions of deaths and tens of millions of patients positive tests. While studies have shown a D614G mutation in the viral spike protein are more transmissible, the effects of this and other mutations on the host response, especially at the cellular level, are yet to be fully elucidated. In this experiment we infected normal human bronchial epithelial (NHBE) cells with the Washington (D614) strain or the New York (G614) strains of SARS-CoV-2. We generated RNA sequencing data at 6, 12, and 24 hours post-infection (hpi) to improve our understanding of how the intracellular host response differs between infections with these two strains. We analyzed these data with a bioinformatics pipeline that identifies differentially expressed genes (DEGs), enriched Gene Ontology (GO) terms and dysregulated signaling pathways. We detected over 2,000 DEGs, over 600 GO terms, and 29 affected pathways between the two infections. Many of these entities play a role in immune signaling and response. A comparison between strains and time points showed a higher similarity between matched time points than across different time points with the same strain in DEGs and affected pathways, but found more similarity between strains across different time points when looking at GO terms. A comparison of the affected pathways showed that the 24hpi samples of the New York strain were more similar to the 12hpi samples of the Washington strain, with a large number of pathways related to translation being inhibited in both strains. These results suggest that the various mutations contained in the genome of these two viral isolates may cause distinct effects on the host transcriptional response in infected host cells, especially relating to how quickly translation is dysregulated after infection. This comparison of the intracellular host response to infection with these two SARS-CoV-2 isolates suggest that some of the mechanisms associated with more severe disease from these viruses could include virus replication, metal ion usage, host translation shutoff, host transcript stability, and immune inhibition.Entities:
Keywords: COVID-19; SARS-CoV-2; bioinformatics; data mining; host response; host-virus; mechanism; virology
Mesh:
Substances:
Year: 2022 PMID: 36204651 PMCID: PMC9530606 DOI: 10.3389/fcimb.2022.1009328
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Fold-change (case vs. control) and adjusted p-values for dysregulated genes at 6hpi for both SARS-CoV-2 isolates.
| Gene | Washington 6hpi | New York 6hpi | |||
|---|---|---|---|---|---|
| Ensembl ID | Gene Symbol | Log2 Fold-change | FDR adjusted p-value | Log2 Fold-change | FDR adjusted p-value |
| ENSG00000236560 |
| 10.9 | 0.00236 | 10.5 | 0.00145 |
| ENSG00000145734 |
| 10.5 | 0.0321 | 9.95 | 0.0198 |
| ENSG00000281618 |
| 8.49 | 0.0171 | 7.47 | 0.028 |
| ENSG00000274129 |
| 5.09 | 0.0268 | 5.02 | 0.012 |
| ENSG00000288461 |
| -10 | 0.0113 | -10 | 0.00505 |
| ENSG00000206287 |
| -9.34 | 0.0157 | -9.34 | 0.00717 |
| ENSG00000285343 |
| -9.34 | 0.0172 | -9.34 | 0.00792 |
| ENSG00000236428 |
| -9.27 | 0.0139 | -9.27 | 0.00655 |
| ENSG00000262526 |
| -8.2 | 0.0369 | -8.2 | 0.0178 |
| ENSG00000275300 |
| -8.3 | 0.00485 | -8.3 | 0.00222 |
Fold-change (case vs. control) and adjusted p-values for dysregulated genes at 12hpi for both SARS-CoV-2 isolates.
| Gene | Washington 12hpi | New York 12hpi | |||
|---|---|---|---|---|---|
| Ensembl ID | Gene Symbol | Log2 Fold-change | FDR adjusted p-value | Log2 Fold-change | FDR adjusted p-value |
| ENSG00000230624 |
| 8.43 | 0.0256 | 7.24 | 0.0421 |
| ENSG00000262660 |
| 8.47 | 0.0124 | 6.35 | 0.0377 |
| ENSG00000249319 |
| 6.22 | 0.0131 | 5.23 | 0.0243 |
| ENSG00000147697 |
| 2.86 | 0.00148 | 2.24 | 0.00959 |
| ENSG00000274746 |
| -8.91 | 0.011 | -8.91 | 0.0076 |
| ENSG00000278174 |
| -9.49 | 0.00881 | -7.99 | 0.0117 |
| ENSG00000236011 |
| -8.44 | 0.00778 | -8.44 | 0.0062 |
Fold-change (case vs. control) and adjusted p-values for dysregulated genes at 24hpi for both SARS-CoV-2 isolates.
| Gene | Washington 24hpi | New York 24hpi | |||
|---|---|---|---|---|---|
| Ensembl ID | Gene Symbol | Log2 Fold-change | FDR adjusted p-value | Log2 Fold-change | FDR adjusted p-value |
| ENSG00000160767 |
| 11.2 | 0.00162 | 11.9 | 0.000179 |
| ENSG00000206324 |
| 11.8 | 4.45E-07 | 11.9 | 2.46E-07 |
| ENSG00000229202 |
| 11.6 | 1.62E-05 | 11.4 | 4.66E-05 |
| ENSG00000257315 |
| 10.9 | 0.0219 | 11.7 | 0.00321 |
| ENSG00000173281 |
| 12.8 | 2.87E-05 | 12.5 | 0.000109 |
| ENSG00000278550 |
| 11 | 0.00538 | 11 | 0.00697 |
| ENSG00000283780 |
| 11.5 | 0.0353 | 11.6 | 0.0357 |
| ENSG00000285526 |
| 10.8 | 0.0365 | 10.9 | 0.0353 |
| ENSG00000100218 |
| -11.1 | 2.16E-05 | -6.3 | 0.000209 |
| ENSG00000164756 |
| -11.7 | 9.07E-06 | -7.07 | 4.82E-05 |
| ENSG00000172482 |
| -2.28 | 0.0456 | -9.37 | 0.000182 |
| ENSG00000180815 |
| -10 | 0.000305 | -10 | 0.000222 |
| ENSG00000259522 |
| -10.5 | 8.32E-05 | -10.5 | 4.28E-05 |
| ENSG00000273291 |
| -10.8 | 0.00164 | -10.8 | 0.00158 |
| ENSG00000273780 |
| -11 | 0.0364 | -11 | 0.0408 |
| ENSG00000280249 |
| -4.06 | 0.000224 | -10.5 | 4.51E-06 |
| ENSG00000285130 |
| -11.5 | 0.0012 | -3.53 | 0.0357 |
Directionality and adjusted p-values for enriched terms across multiple time points and SARS-CoV-2 isolates.
| Database | Term | New York 6hpi | Washington 6hpi | New York 12hpi | Washington 12hpi | ||||
|---|---|---|---|---|---|---|---|---|---|
| FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | ||
| GO | Detoxification of inorganic compound | 0.00043 | Down | 0.000104 | Down | 0.000353 | Down | 2.05E-06 | Down |
| Reactome | Metallothioneins bind metal | 0.00126 | Down | 0.000104 | Down | 0.001844 | Down | 1.70E-05 | Down |
| Reactome | Response to metal ions | 0.0086 | Down | 0.000813 | Down | 0.00269 | Down | 6.25E-05 | Down |
| Hallmark | Amit serum response 120 MCF10A | 0.001 | Up | 0.018998 | Up | 0.01118 | Up | ||
| Hallmark | Dazard UV response cluster G28 | 0.00043 | Up | 0.000602 | Up | 0.042113 | Up | ||
| GO | Lung vasculature development | 0.00043 | Up | 0.000813 | Up | 0.033232 | Up | ||
| Hallmark | Lin silenced by tumor microenvironment | 0.00043 | Up | 0.003791 | Up | 0.0189 | Up | ||
| GO | Calcium independent cell-cell adhesion | 0.00341 | Up | 0.00403 | Up | 0.014062 | Up | ||
| Reactome | Tight junction interactions | 0.01483 | Up | 0.01118 | Up | 0.034701 | Up | ||
| GO | Cellular response to zinc ion | 0.009728 | Down | 0.033232 | Down | 0.009274 | Down | ||
| Hallmark | Zheng response to arsenite up | 0.049621 | Down | 0.013182 | Down | 0.000588 | Down | ||
| Hallmark | Blanco Melo Beta interferon treated bronchial epithelial cells up | 0.00341 | Up | 0.013182 | Up | ||||
| Hallmark | Blanco Melo COVID-19 bronchial epithelial cells SARS-Cov-2 infection up | 0.00043 | Up | 0.033232 | Up | ||||
| Hallmark | Blanco Melo COVID-19 SARS-CoV-2 infection Calu-3 cells up | 0.00643 | Up | 0.006878 | Up | ||||
| Hallmark | Blanco Melo human parainfluenza virus 3 infection A549 cells up | 0.00045 | Up | 0.027899 | Up | ||||
| GO | CXCR chemokine receptor binding | 0.01568 | Up | 0.013182 | Up | ||||
| Hallmark | Hecker IFNB1 targets | 0.00043 | Up | 0.009306 | Up | ||||
| Hallmark | Moserle IFNA response | 0.00341 | Up | 0.003021 | Up | ||||
| Reactome | Cholesterol biosynthesis | 0.00318 | Down | 0.003408 | Down | ||||
| GO | Farnesyl diphosphate metabolic process | 0.01853 | Down | 0.01118 | Down | ||||
| Hallmark | Schmidt POR targets in limb bud up | 0.00064 | Down | 0.000353 | Down | ||||
| Hallmark | Weng POR targets global up | 0.03123 | Down | 0.00687 | Down | ||||
| WP | Cholesterol biosynthesis pathway | 0.00047 | Down | 0.000353 | Down | ||||
| WP | Mevalonate pathway | 0.00142 | Down | 0.001967 | Down | ||||
| Hallmark | Horton SREBF targets | 0.00085 | Down | 0.000618 | Down | ||||
| Reactome | Interleukin 10 signaling | 0.00017 | Up | 0.000529 | Up | ||||
| GO | Positive regulation of immature T-cell proliferation | 0.00081 | Up | 0.002769 | Up | ||||
| GO | Regulation of adiponectin secretion | 0.00498 | Up | 0.010201 | Up | ||||
| Hallmark | Onder CDH1 targets 3 down | 0.00028 | Up | 0.010201 | Up | ||||
| Hallmark | Dazard UV response cluster G2 | 0.00251 | Up | 0.003791 | Up | ||||
| Hallmark | Liang silenced by methylation down | 0.01779 | Down | 0.02866 | Up | ||||
| Hallmark | Browne interferon responsive genes | 0.00043 | Up | ||||||
| Hallmark | Croonquist IL6 deprivation down | 0.00111 | Down | ||||||
| Hallmark | Blanco Melo bronchial epithelial cells Influenza A delNS1 infection down | 0.00043 | Down | ||||||
| Hallmark | Graham normal quiescent vs normal dividing down | 0.0012 | Down | ||||||
| Hallmark | Kang doxorubicin resistance up | 0.00142 | Down | ||||||
| Hallmark | Rosty cervical cancer prolieration cluster | 0.0012 | Down | ||||||
| GO | Gas transport | 0.009248 | Up | ||||||
| Hallmark | Shin B-cell lymphoma cluster 6 | 0.002769 | Up | ||||||
| Hallmark | Amit delayed early genes | 0.014027 | Up | ||||||
| Hallmark | Bowie response to tamoxifen | 0.011965 | Up | ||||||
| GO | Regulation of cellular pH reduction | 0.037071 | Up | ||||||
| HP | Orthokeratosis | 0.009274 | Up | ||||||
| Hallmark | Montero thyroid cancer poor survival up | 0.009274 | Up | ||||||
| Hallmark | Fung IL2 signaling 2 | 0.00375 | Down | ||||||
| GO | Box C/D snoRNP complex | 0.002785 | Down | ||||||
| GO | Small subunit processome | 0.013573 | Down | ||||||
| Hallmark | Nadella PRKAR1A targets down | 0.009274 | Down | ||||||
| Reactome | rRNA modification in the nucleus and cytosol | 0.021817 | Down | ||||||
Directionality and adjusted p-values for enriched terms associated with metal ions across multiple time points and SARS-CoV-2 isolates.
| Database | Term | New York 6hpi | Washington 6hpi | New York 12hpi | Washington 12hpi | ||||
|---|---|---|---|---|---|---|---|---|---|
| FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | ||
| GO | Detoxification of inorgainc compound | 0.00043 | Down | 0.000104 | Down | 0.000353 | Down | 2.05E-06 | Down |
| Reactome | Metallothioneins bind metal | 0.00126 | Down | 0.000104 | Down | 0.001844 | Down | 1.70E-05 | Down |
| Reactome | Response to metal ions | 0.0086 | Down | 0.000813 | Down | 0.00269 | Down | 6.25E-05 | Down |
| Hallmark | Amit serum response 120 MCF10A | 0.001 | Up | 0.018998 | Up | 0.01118 | Up | ||
| Hallmark | Dazard UV response cluster G28 | 0.00043 | Up | 0.000602 | Up | 0.042113 | Up | ||
| GO | Lung vasculature development | 0.00043 | Up | 0.000813 | Up | 0.033232 | Up | ||
| Hallmark | Lin silenced by tumor microenvironment | 0.00043 | Up | 0.003791 | Up | 0.0189 | Up | ||
| GO | Calcium independent cell-cell adhesion | 0.00341 | Up | 0.00403 | Up | 0.014062 | Up | ||
| Reactome | Tight junction interactions | 0.01483 | Up | 0.01118 | Up | 0.034701 | Up | ||
| GO | Cellular response to zinc ion | 0.009728 | Down | 0.033232 | Down | 0.009274 | Down | ||
| Hallmark | Zheng response to arsentite up | 0.049621 | Down | 0.013182 | Down | 0.000588 | Down | ||
Directionality and adjusted p-values for enriched terms associated with host immune response across multiple time points with the New York isolate of SARS-CoV-2.
| Database | Term | New York 6hpi | New York 12hpi | ||
|---|---|---|---|---|---|
| FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | ||
| Hallmark | Blanco Melo Beta interferon treated bronchial epithelial cells up | 0.00341 | Up | 0.013182 | Up |
| Hallmark | Blanco Melo COVID-19 bronchial epithelial cells SARS-Cov-2 infection up | 0.00043 | Up | 0.033232 | Up |
| Hallmark | Blanco Melo COVID-19 SARS-CoV-2 infection Calu-3 cells up | 0.00643 | Up | 0.006878 | Up |
| Hallmark | Blanco Melo human parainfluenza virus 3 infection A549 cells up | 0.00045 | Up | 0.027899 | Up |
| GO | CXCR chemokine receptor binding | 0.01568 | Up | 0.013182 | Up |
| Hallmark | Hecker IFNB1 targets | 0.00043 | Up | 0.009306 | Up |
| Hallmark | Moserle IFNA response | 0.00341 | Up | 0.003021 | Up |
| Reactome | Cholesterol biosynthesis | 0.00318 | Down | 0.003408 | Down |
| GO | Farnesyl diphosphate metabolic process | 0.01853 | Down | 0.01118 | Down |
| Hallmark | Schmidt POR targets in limb bud up | 0.00064 | Down | 0.000353 | Down |
| Hallmark | Weng POR targets global up | 0.03123 | Down | 0.00687 | Down |
| WP | Cholesterol biosynthesis pathway | 0.00047 | Down | 0.000353 | Down |
| WP | Mevalonate pathway | 0.00142 | Down | 0.001967 | Down |
| Hallmark | Horton SREBF targets | 0.00085 | Down | 0.000618 | Down |
Directionality and adjusted p-values for enriched terms identified at 6hpi with either the New York or Washington isolate of SARS-CoV-2.
| Database | Term | New York 6hpi | Washington 6hpi | ||
|---|---|---|---|---|---|
| FDR adjusted p-value | Direction | FDR adjusted p-value | Direction | ||
| Reactome | Interleukin 10 signaling | 0.00017 | Up | 0.000529 | Up |
| GO | Positive regulation of immature T-cell proliferation | 0.00081 | Up | 0.002769 | Up |
| GO | Regulation of adiponectin secretion | 0.00498 | Up | 0.010201 | Up |
| Hallmark | Onder CDH1 targets 3 down | 0.00028 | Up | 0.010201 | Up |
| Hallmark | Dazard UV response cluster G2 | 0.00251 | Up | 0.003791 | Up |
All significant positively (+) or negatively (-) dysregulated intracellular signaling pathways across multiple time points with either SARS-CoV-2 isolate.
| Pathway name | NY 6hr | NY 12hr | NY 24hr | WA 6hr | WA 12hr | WA 24hr |
|---|---|---|---|---|---|---|
| Cell cycle | 0.022257 (-) | |||||
| Keratinization | 0.001558 (+) | 0.017467 (+) | ||||
| Stabilization and expansion of the E-cadherin adherens junction | 0.017463 (+) | |||||
| Alzheimer disease-presenilin pathway | 0.004439 (+) | |||||
| Plasminogen activating cascade | 0.007253 (-) | 0.034549 (-) | 0.036979 (-) | |||
| Integrin signalling pathway | 0.007253 (+) | |||||
| Regulation of actin cytoskeleton | 0.035812 (-) | 0.010134 (+) | ||||
| Signaling by TGF-beta Receptor Complex | 0.00051 (+) | |||||
| mTOR signaling pathway | 0.049417 (-) | |||||
| Olfactory transduction | 0.000384 (-) | 1.58E-05 (-) | ||||
| Peptide chain elongation | 4.76E-09 (-) | 1.62E-08 (-) | ||||
| Nonsense-Mediated Decay (NMD) | 4.76E-09 (-) | 1.39E-05 (-) | ||||
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 4.76E-09 (-) | 1.39E-05 (-) | ||||
| Eukaryotic Translation Elongation | 4.76E-09 (-) | 3.23E-09 (-) | ||||
| Eukaryotic Translation Termination | 1.63E-06 (-) | 1.63E-06 (-) | ||||
| Translation | 7.03E-05 (-) | 0.000295 (-) | ||||
| SRP-dependent cotranslational protein targeting to membrane | 0.000171 (+) | 0.000204 (-) | ||||
| GTP hydrolysis and joining of the 60S ribosomal subunit | 0.000417 (-) | 0.000238 (-) | ||||
| Eukaryotic Translation Initiation | 0.001691 (-) | 0.000295 (-) | ||||
| Cap-dependent Translation Initiation | 0.001691 (-) | 0.000295 (-) | ||||
| rRNA processing in the nucleus and cytosol | 0.004313 (-) | 3.78E-13 (-) | ||||
| PDGFR-beta signaling pathway | 0.010419 (+) | 0.003059 (+) | ||||
| Apoptosis | 1.59E-05 (+) | |||||
| Amyotrophic lateral sclerosis (ALS) | 0.001498 (+) | |||||
| MAPK signaling pathway | 0.002158 (+) | |||||
| Hippo signaling pathway | 0.006153 (+) | |||||
| Major pathway of rRNA processing in the nucleolus and cytosol | 3.32E-13 (-) | |||||
| rRNA processing | 4.45E-13 (-) | |||||
| Gene Expression | 0.000162 (-) |
NY, New York; WA, Washington; “+”, Activated; “-”, Inhibited.